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Receptor-mediated endocytosis is a constitutive high
capacity pathway for the reabsorption of proteins from
the glomerular filtrate by the renal proximal tubule.
ClC-5 is a voltage-gated chloride channel found in the
proximal tubule where it has been shown to be essential
for protein uptake, based on evidence from patients
with Dent’s disease and studies in ClC-5 knockout mice.
To further delineate the role of ClC-5 in albumin uptake,
we performed a yeast two-hybrid screen with the C-
terminal tail of ClC-5 to identify any interactions of the
channel with proteins involved in endocytosis. We found
that the C-terminal tail of ClC-5 bound the actin depo-
lymerizing protein, cofilin, a result that was confirmed
by GST-fusion pulldown assays. In cultured proximal
tubule cells, cofilin was distributed in nuclear, cytoplas-
mic, and microsomal fractions and co-localized with
ClC-5. Phosphorylation of cofilin by overexpressing LIM
kinase 1 resulted in a stabilization of the actin cytoskel-
eton. Phosphorylation of cofilin in two proximal tubule
cell models (porcine renal proximal tubule and opossum
kidney) was also accompanied by a pronounced inhibi-
tion of albumin uptake. This study identifies a novel
interaction between the C-terminal tail of ClC-5 and
cofilin, an actin-associated protein that is crucial in the
regulation of albumin uptake by the proximal tubule.
One of the major roles of the cortical nephron is to reabsorb
proteins such as albumin from the glomerular filtrate. It is
estimated that the kidneys reabsorb up to several grams of
albumin/day, a process that is achieved in the proximal tubule
by highly active and tightly regulated receptor-mediated endo-
cytosis involving the megalin-cubulin scavenger receptor com-
plex (1). It is now clear that the uptake of albumin requires the
coordinated activity of a number of proteins that may exist in a
macromolecular complex within the endosome. This complex
seems to include the albumin receptor megalin, V-type H-
ATPase, Na-H exchanger isoform 3 (NHE3),1 and the Cl
channel ClC-5 (2–4). These proteins have defined transport
functions that account for the various ion movements required
during endosomal formation and acidification. V-type H-
ATPase plays a critical role in the acidification of the endo-
some, leading to dissociation of the albumin from megalin and
its subsequent degradation in the lysosome (4). ClC-5 is
thought to be essential to provide the necessary anion shunt to
neutralize the positive charge caused by H movement by the
V-type H-ATPase during the acidification of the endosome as
it progresses to the lysosome (5, 6). NHE3 may play a facilita-
tory role in mediating the initial acidification process by ex-
changing the high Na for H in the newly formed endosome as
it buds away from the membrane (3).
The functional importance of these proteins in mediating
albumin uptake has been shown in genetic disorders and in cell
culture models. ClC-5 is essential for albumin uptake. In Dent’s
disease, which is caused by mutations in ClC-5, one of the key
outcomes is low molecular weight proteinuria (6). Furthermore,
ClC-5 knockout mice also have proteinuria and in both of these
cases, the proteinuria is caused by defective protein uptake in
the proximal tubule (6, 7). This effect is thought to be caused by
the key role of ClC-5 as an anion shunt, as the rate of acidifi-
cation of apical vesicles derived from ClC-5 knockout mice is
significantly lower than that observed in vesicles derived from
wild-type mice (6). As a result, the uptake of markers of recep-
tor-mediated and fluid phase endocytosis is severely impaired
in the kidneys of ClC-5 knockout mice (6, 7). In addition, NHE3
activity also seems to be involved in albumin uptake. In cul-
tured opossum kidney (OK) cells or porcine renal proximal
tubule (LLC-PK1) cells (8), inhibition of NHE3 with 5-(N-ethyl-
N-isopropyl)-amiloride inhibits albumin uptake, and in OK
cells lacking NHE3, albumin uptake is abolished (3). In con-
trast to ClC-5 knockout mice, however, there are no reports of
proteinuria in NHE3 knockout mice, which argues against an
obligate role for NHE3 in albumin uptake in vivo. In addition to
mediating ion transport, both ClC-5 and NHE3 possess large
intracellular C-terminal tails which can interact with scaffold
or regulatory proteins in the cytoplasm, an essential compo-
nent of the endocytotic pathway (9). For example, the binding
of sodium-hydrogen exchange regulatory factor to the PDZ
binding domain of NHE3 (the subject of extensive study) me-
diates the interaction of NHE3 with the actin cytoskeleton (10,
11) and forms localized signaling complexes for regulation by
protein kinase A (12) and PI-3 kinase (13). In addition, NHE3
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has been shown to interact with megalin by means of C-termi-
nal interactions (14).
In contrast, despite ClC-5 being essential for the uptake of
albumin, little is known about the functional interactions of the
intracellular C terminus of ClC-5. The terminus contains a
number of potential binding signals for regulatory molecules,
including cystathione- synthase domain (15, 16), a PY motif
(17), and a PDZ binding domain. Thus, it is possible that ClC-5
may play a crucial role in regulating endocytosis by means of
C-terminal interactions with other proteins involved in the
endocytotic pathway in the proximal tubule. We have recently
shown that horseradish peroxidase infused into the kidneys of
ClC-5 knockout mice remains trapped in a sub-plasmalemmal
pre-endocytotic compartment and fails to enter the endosomal
pathway proper (7). This finding suggests that the endocytotic
defect may also be occurring earlier, at the formation of the
nascent endosome, and that this may be because of interactions
of ClC-5 with proteins involved in regulating the endocytotic
process. Another possibility is trafficking, with evidence for
this role for ClC-5 in the trafficking of other membrane pro-
teins provided by studies in patients with Dent’s disease, where
defective ClC-5 resulted in the mis-trafficking of the V-type
H-ATPase (18) and in ClC-5 knockout mice, where mis-traf-
ficking results in reduced levels of megalin/cubulin at the
plasma membrane (19).
The internalization of the albumin-megalin complex occurs
by means of clathrin-coated pits (20). The processes by which
clathrin-coated pits are formed, recruit cargo, and detach as
nascent endosomes are well characterized. The series of events,
however, that allows the nascent endosome to pass through the
cortical actin web into the cytoplasm are less well understood.
Although albumin endocytosis is known to require intact cy-
toskeletal structures (21), the exact nature of the role of the
cytoskeleton remains to be elucidated. The cytoskeleton itself
may present a physical barrier to the endocytotic machinery
(22, 23), and therefore some localized remodeling of the net-
work filaments must occur for the endosome to pass into the
cytoplasm. In fact, it has been observed that the area in the
immediate vicinity of clathrin-coated pits is largely devoid of
actin filaments (24). One way this can be achieved is by the
dissolution of actin filaments in the immediate vicinity of the
endosome by actin depolymerizing proteins. The rapid turnover
of actin filaments and the tertiary meshwork formation is
regulated by a variety of actin-binding proteins such as the
actin-depolymerizing factor/cofilin proteins (25). These pro-
teins are potent regulators of actin filament dynamics in eu-
karyotic cells and mediate the severing and depolymerization
of actin. The actin-depolymerizing factor/cofilin family has
been shown to play a crucial role in mediating microvillar
breakdown and rapid cytoskeletal alterations in ischemic and
ATP-depleted proximal tubule cells (26).
Therefore, we performed yeast two-hybrid screens to deter-
mine whether the C terminus of ClC-5 interacts with proteins
involved in endocytosis. This revealed a novel interaction be-
tween the C terminus of ClC-5 and the actin binding protein,
cofilin. These proteins co-localize in vesicles containing the
endosomal marker AP-2. Furthermore, we demonstrated that
phosphorylation of cofilin by LIM kinase inhibits albumin up-
take in two model proximal tubule cell lines, namely LLC-PK1
and OK cells. Our data suggest that the interaction between
cofilin and ClC-5 plays a critical regulatory role in the reab-
sorption of low molecular weight proteins in the proximal
tubule.
MATERIALS AND METHODS
Cells and Antibodies—The LLC-PK1 and OK cell lines were obtained
from American Type Culture Collection. LLC-PK1 cells were main-
tained in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum, 1% penicillin and streptomycin, whereas OK cells
were maintained in Dulbecco’s modified Eagle’s medium/Ham’s-F12
media supplemented with 10% fetal bovine serum, 1% penicillin and
streptomycin and incubated at 37 °C in 5% CO2. Polyclonal antibodies
against the N terminus of human ClC-5 were generated in rabbits
immunized with keyhole limpet hemocyanin conjugated with synthetic
peptide (CKSRDRDRHREITNKS), corresponding to amino acids 26–40
near the N terminus of ClC-5 with an additional N-terminal cysteine.
Anti-ClC-5 IgG was affinity-purified with a column containing 5 mg of
peptide (Eurogenetec, Seraing, Belgium). Anti-glutathione S-transfer-
ase (GST) was purchased from Amersham Biosciences. Anti-cofilin was
purchased from Cytoskeleton Inc. (Denver, CO). Anti-c-myc was pur-
chased from Roche Applied Science. Anti-actin was purchased from
Chemicon (Temecula, CA). TRITC-phalloidin was purchased from
Sigma. All secondary alkaline phosphatase-conjugated antibodies were
obtained from Bio-Rad. Labeled secondary antibodies were obtained
from Jackson ImmunoResearch (West Grove, PA).
Cloning of Human ClC-5 cDNA and Construction of Bait Vectors—
Human ClC-5 (hClC-5) cDNA was isolated from a human kidney
Matchmaker cDNA library (Clontech, Palo Alto, CA) using reverse
transcriptase-PCR with the forward and reverse primers and cloned
into the pGEM-T Easy Vector (Promega, Madison, WI). Plasmid DNA
was screened for the desired insert by restriction analysis, sequenced
entirely by automated DNA sequencing (performed at the Johns Hop-
kins University Biosynthesis and Sequencing Facility), and confirmed
to be human ClC-5. The full-length C-terminal tail of ClC-5 (amino
acids 563–746) was then cloned into the two-hybrid bait vector pAS2-1
and designated FBD. In addition, the C-terminal tail was divided into
three regions and cloned into pAS2-1. These three regions isolated the
two CBS regions (CBS1, amino acids 595–645, and CBS2, amino acids
686–733) and the region encompassing the PY domain (amino acids
646–685).
Yeast Two-hybrid Analysis—Two-hybrid analysis was performed by
using the Matchmaker human kidney cDNA library (Clontech) and
screened for interacting proteins by transformation of Y190 yeast on
selective minimal synthetic dropout medium (Leu-, Trp-, His-, 35 mM
3-amino-1,2,4-triazole) at 30 °C for 2–7 days. A -galactosidase assay
confirmed the interactions. To confirm the interactions with cofilin, a
bait pACT2 vector expressing cofilin was created (Cofilin).
GST-cofilin Pulldown Assay—Cofilin was cloned into the pGEX-6P-1
(Amersham Biosciences) vector using the EcoRI and XhoI sites (GST-
cofilin). The GST-cofilin fusion protein was produced by using the GST
purification kit (Amersham Biosciences) following the manufacturer’s
instructions. Expression of the GST fusion protein was induced with 1
mM isopropyl-1-thio--D-galactopyranoside, cells were lysed by sonica-
tion, and the GST fusion protein was purified by using a glutathione-
Sepharose 4B column. For the pulldown assay, 50 g of GST or GST-
cofilin fusion protein was incubated with glutathione-Sepharose 4B
beads (Amersham Biosciences) for 3 h at 4 °C. The beads were then
washed by centrifugation and incubated with 1 mg of lysate from
LLC-PK1 cells at 4 °C for 18 h. The beads were then washed, the
samples were eluted into Laemmli gel sample buffer, separated on a
12% SDS-PAGE, and transferred to polyvinylidene difluoride mem-
branes. Western blotting was performed using the anti-ClC-5 and anti-
GST antibodies, and the blots were detected by using secondary anti-
bodies conjugated to alkaline phosphatase.
Intracellular Distribution of Cofilin—LLC-PK1 cells were scraped
into suspension buffer (10 mM Tris-HCl, 1 mM EDTA), and the mem-
branes were disrupted by passing the sample through a 25-gauge nee-
dle 20 times. Nuclear, cytosolic, and microsomal fractions were har-
vested as described previously (27). Briefly, the nuclei were harvested
by centrifugation at 10,000  g, and the postnuclear supernatant was
centrifuged at 100,000  g for 90 min. The pellet (microsomal fraction)
was suspended in suspension buffer. The supernatant was centrifuged
at 100,000  g for 45 min, and the subsequent supernatant was col-
lected (cytosolic fraction). Equal volumes of protein fractions were re-
solved on 4–15% Tris-HCl gradient gels, and cofilin was detected by
Western blotting as described above.
Confocal Microscopy of Endogenous ClC-5 and Cofilin—Cells (LLC-
PK1 or OK) grown on glass coverslips were fixed in 4% paraformalde-
hyde in 0.1 M phosphate-buffered saline (PBS), pH 7.2, for 10 min and
permeabilized for 1 min with an ice-cold solution of 0.1% (v/v) Triton
X-100 in PBS, 1% (v/v) normal donkey serum. Cells were washed three
times in PBS, and the non-antigenic sites were blocked with 1% (v/v)
normal donkey serum for 30 min. Incubation with the primary antibod-
ies was performed at 37 °C for 30 min. To co-label the samples for ClC-5
and cofilin, the following protocol was employed (28). Samples were first
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incubated with rabbit anti-ClC-5, then with goat anti-rabbit to block
any non-bound sites on the rabbit antibody, and finally with donkey
anti-goat conjugated to TRITC. Cofilin was then labeled cofilin with the
anti-cofilin antibody and subsequently with a Cy2-conjugated goat anti-
rabbit secondary. Between each antibody exposure, samples were
washed three times for 10 min in PBS to eliminate nonspecific binding
of the antibodies and cross-reactivity. Samples were then mounted in
Vectashield (Vector, Burlingame, CA) and viewed with a Noran Oz
confocal microscope fitted with a 100 oil immersion objective.
Analysis of LIMK-1-transfected Cells—LLC-PK1 cells were tran-
siently transfected with a c-myc-tagged LIMK-1 in pCDNA3 (kindly
provided by Dr. Pico Caroni, Friedrich Miescher Institute, Switzerland)
using NovaFector (Venn Nova, Pompano Beach, FL). Expression of the
c-myc LIMK-1 was confirmed by using a monoclonal c-myc antibody
Western blot analysis. An antibody that specifically binds to phospho-
rylated cofilin (29) (generously provided by Dr. James Bamburg, Colo-
rado State University, Fort Collins, CO) was used to detect the phos-
phorylated cofilin. Equal loading of samples was confirmed by using an
actin antibody as a control. To determine the effects of LIMK-1 overex-
pression on the actin distribution, transfected cells were fixed, perme-
abilized, and labeled with TRITC-phalloidin (1 g/ml) for 20 min, and
LIMK-1 was detected by using the c-myc antibody as described above.
Albumin Uptake—We used two different methods to measure the
effects of LIMK-1 overexpression on albumin uptake in cultured prox-
imal tubule cells. The first method used a modified albumin uptake
method in OK cells, a cell line commonly used for the study of proximal
tubule albumin uptake (3, 9, 30). Control (mock-transfected) OK cells or
cells transfected with c-myc-LIMK-1 were grown in 48-well plates for 7
days. In the final 48 h prior to experimentation, cells were changed to
serum-free medium. Then cells were exposed to 50 g/ml albumin
conjugated to Texas Red (TR-albumin, Molecular Probes, Eugene, OR)
under different conditions for 120 min. As a control to determine the
level of endocytosis dependent on the intact cytoskeleton, some cells
were pre-treated with latrunculin A (1.5 M) for 60 min before exposure
to TR-albumin. Nonspecific binding was determined in cells exposed to
albumin for 1 min, a time at which no albumin uptake could be de-
tected. At the end of the uptake period, cells were washed in HEPES
buffer, pH 6, at 4 °C and then lysed in MOPS buffer (20 mM MOPS with
0.1% Triton X-100). The TR-albumin fluorescence was determined by
using a Fusion spectrophotometer (Hewlett Packard, Blackburn, Victo-
ria, Australia) at 580 nm excitation and 630 nm emission wavelengths.
TR-albumin uptake was standardized to total cellular protein, and
the amount of fluorescence/g of cellular protein was adjusted for
background.
To confirm the effects of LIMK-1 overexpression on albumin uptake
in proximal tubule cells, we used single cell confocal microscopic anal-
ysis and a different proximal tubule cell line, LLC-PK1 (31). LLC-PK1
cells have also been shown to take up albumin at a rate comparable
with OK cells. LLC-PK1 cells grown on coverslips and transfected with
c-myc-LIMK-1 were exposed to fluorescein isothiocyanate-albumin (10
mg/ml) at 37 °C and incubated at times from 0 to 15 min. At the end of
each time point, the cells were washed thoroughly in PBS and fixed as
described above for confocal microscopy. Expression of c-myc LIMK-1
was detected with anti-c-myc antibody, and secondary antibody was
conjugated to Cy3. The rate of albumin uptake was measured by aver-
aging the fluorescence intensity of 10 individual control cells at each of
the time points using Interaction and Presentation Laboratory software
version 3.5. Parallel experiments were performed on untransfected
control cells, on cells held at 4 °C to abolish endocytosis, and on cells
pretreated with 30 M cytochalasin D for 30 min to disrupt the actin
cytoskeleton and inhibit endocytosis. For the LIMK-1 transfected cells,
only those cells determined to be positive for c-myc LIMK-1 expression
were analyzed.
Detection of LIMK-1 and LIMK-2 by Reverse Transcriptase-PCR
Analysis—RNA was extracted from OK cells using Trizol reagent and
the manufacturer’s protocol. 2 g of RNA was reverse transcribed using
Superscript III (Invitrogen) and an aliquot analyzed by PCR using the
following primers: LIMK-1 forward, 5-GTGATGGGGACACCTACA-
CACTGG-3; LIMK-1 reverse, 5-GGAGCAGGCGGCTGGTCTCCTGG-
3; LIMK-2 forward, 5-TCCTCCTCCCCATTTCCGGGCTCC-3; LIM-
K-2 reverse, 5-TCTGTGGAGAGTCTCTCAAACATG-3. -Actin was
amplified as a control for reverse transcriptase-PCR.
Quantification of Results and Statistical Analysis—Densitometric
analysis of the Western blot data was performed using Fujifilm Sci-
enceLab 99 Image Gauge (version 3.3). The percent co-localization
between cofilin and ClC-5 was determined by using the Ultraview
software co-localization function. The data were obtained from eight
images composed of at least five cells in each view and reported as
percent co-localization  S.E. Statistical analyses of the data were
performed with two-tailed Student’s paired t tests; p  0.05 was con-
sidered significant.
RESULTS
Yeast Two-hybrid Screen—The yeast two-hybrid screen of a
human kidney cDNA library using the C terminus of human
ClC-5 revealed an interaction with a clone (82-5) that coded for
non-muscle isoform of cofilin (cofilin1) (GenBankTM accession
number NM005507). This cDNA was subcloned, and a subse-
quent two-hybrid screen confirmed the interaction between
cofilin and ClC-5 (Table I). We then used the C-terminal frag-
ments to attempt to identify the residues responsible for the
interaction with cofilin. Unlike the interaction with the full-
length tail, we found that none of the C-terminal fragments
(CBS1, CBS2, or PY) interacted with cofilin in the two-hybrid
assay.
GST Pulldown—To confirm an interaction between cofilin
and ClC-5 in mammalian cells, we performed GST pulldowns.
A GST-cofilin fusion protein was produced in BL-21 Esche-
richia coli and bound to glutathione-Sepharose beads. Lysate
from LLC-PK1 cells was applied to the beads, and after wash-
ing, the protein bound to the beads was eluted, separated by
SDS-PAGE, and Western blotted. The Western blots were then
probed with the antibody against ClC-5. In control lysates
incubated with GST alone, there was a nonspecific band at50
kDa (data not shown). However, in lysates incubated with
GST-cofilin, there was a clear band at 85 kDa corresponding
to ClC-5 (Fig. 1A). This experiment was performed three times,
and it was found that there was a significant level (p  0.001)
of ClC-5 binding to GST-cofilin compared with GST alone (Fig.
1B). These data confirm the interaction between endogenous
ClC-5 and cofilin in cells of proximal tubule origin.
Cellular Distribution of Cofilin—Cofilin is widely distributed
throughout the cytoplasm and nuclei of cells and can translo-
cate to the plasma membrane in response to various stimuli
(23). Cofilin has no predicted transmembrane domains; there-
fore, its association with cellular membranes is caused by in-
teractions with proteins in or associated with these mem-
branes. Therefore, we investigated the distribution of cofilin in
nuclear, cytoplasmic, and microsomal fractions of LLC-PK1
cells. We found that in addition to being in the nucleus and
cytoplasm, a significant fraction of the cofilin was associated
with the microsomal membranes (Fig. 2). This association in-
dicated that cofilin must be associating constitutively with
other membrane-bound proteins in these cells, which is con-
sistent with the high levels of ClC-5 found in these fractions.
Subcellular Localization of Cofilin and ClC-5—We then per-
TABLE I
Yeast two-hybrid analysis of the interaction between ClC-5 and cofilin
Yeast two-hybrid analysis identifies an interaction between ClC-5
and cofilin. Fragments, as well as the entire C terminus of ClC-5, were
cloned into pACT2 and pAS2–1 vectors. Yeast two-hybrid analysis was
performed using the Matchmaker system. Interactions were deemed
positive by growth on selective media and a positive -galactosidase
assay. Both the full-length cofilin as well as a clone that contained an
additional 17 amino acids in frame from the 5-untranslated region
(clone 82–5) were able to interact with the C terminus of ClC-5 (FBD).
Smaller regions of the C terminus of ClC-5, namely CBS1, CBS2, and
PY, were not able to bind to cofilin.
pACT2 pAS2–1 Interaction?
No insert FBD No
Clone 82–5 FBD Yes
Cofilin FBD Yes
Cofilin CBS1 No
Cofilin CBS2 No
Cofilin PY No
Cofilin No insert No
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formed dual wavelength confocal microscopy on permeabilized
cells using antibodies against cofilin and ClC-5 to demonstrate
co-localization. We found that endogenous ClC-5 occurred in
punctate structures throughout the cytoplasm, which is con-
sistent with its presence in recycling endosomes (Fig. 3A).
Cofilin also showed a similar distribution (Fig. 3B), and when
the two images were overlaid, there was clear co-localization of
the two proteins (Fig. 3C). Pixel density analysis confirmed
that there was a significant degree of co-localization of 63.0 
11.6% (p  0.005; n  10). Furthermore, we also found that the
marker of budding endosomes, AP-2 (Fig. 3D), also co-localized
with cofilin and ClC-5 (Fig. 3E). Analysis of a z-scan of polar-
ized LLC-PK1 cells indicated that ClC-5 (Fig. 3F) and co-
filin (Fig. 3G) co-localized in the subapical region of the cell
(Fig. 3H).
Phosphorylation of Cofilin by LIMK-1—We then investigated
whether we could modulate the activity of cofilin in cultured
proximal tubule cells. Cofilin is a phosphoprotein which, when
phosphorylated, is unable to interact with actin microfila-
ments. Cofilin is presently the only known substrate of LIM
kinase, of which there are two isoforms, LIMK-1 and LIMK-2
(31). In OK cells, we detected transcript for LIMK-1 but could
not detect any RNA transcript for LIMK-2 (data not shown).
LLC-PK1 cells were transfected with c-myc epitope-tagged
LIMK-1 for 48 h, and Western blots were performed on the
cellular lysates. An anti-c-myc antibody confirmed that there
was a significant expression of LIMK-1 in the cells (Fig. 4A).
We then probed the same cellular lysates on Western blots by
using an antibody directed against the phosphorylated form of
cofilin. The over-expression of LIMK-1 in LLC-PK1 cells re-
sulted in a significant increase in the phosphorylation level of
endogenous cofilin (p  0.05; n  3) (Fig. 4, B and C). It is
important to note that the transfection efficiency of these ex-
periments was approximately 30–50% as assessed by trans-
fection with green fluorescent protein (data not shown); there-
fore, the increase in the phosphorylation of cofilin measured
was a considerable underestimate of the increase in transfected
cells, as the lysate included both transfected and untransfected
cells.
Next we determined whether phosphorylation of cofilin by
LIMK-1 resulted in any alterations in the morphology of the
actin cytoskeleton. OK cells transfected with c-myc-LIMK-1
were fixed and double-labeled with anti-c-myc antibody and
TRITC-phalloidin. Confocal microscopy was used to determine
the changes in the actin cytoskeleton in cells exposed to the
actin filament disrupting agent latrunculin A or in cells ex-
pressing LIMK-1. In control cells, there was pronounced actin
staining at the peripheral corona as well as at the bases of the
microvilli (Fig. 5A). The z axis scans revealed the typical pe-
ripheral distribution of actin at the apical and basolateral
domains (Fig. 5B). In contrast, in cells treated with latrunculin
A, the microfilaments were severely disrupted with staining,
almost disappearing from the apical domain and the microvil-
lar region (Fig. 5, C and D). In cells expressing LIMK-1, there
was an apparent increase in TRITC-phalloidin staining at the
cell periphery of the cells consistent with stabilization of actin
filaments (Fig. 5, E–H). There was also a pronounced increase
in the amount of actin at the base of the microvilli compared
with control cells (Fig. 5, E and F; cf. Fig. 5A), indicating
stabilization of the microfilaments in the regions where albu-
min uptake is thought to occur.
ClC-5 is essential for albumin uptake, and we demonstrated
that ClC-5 binds to cofilin. Therefore, we investigated whether
altering the phosphorylation state of cofilin with LIMK-1 and
stabilization of actin microfilaments had any effect on albumin
endocytosis in cultured proximal tubule cells. In OK cells ex-
pressing LIMK-1, there was a significant reduction in the up-
take of TR-albumin (Molecular Probes) to 67.0  3.5% (n  4;
p  0.05) of control mock-transfected levels (Fig. 6A). As men-
tioned previously, the transfection efficiency in OK cells under
these conditions is of the order of 30–50%; therefore, the 35%
reduction in albumin uptake observed in the total population of
cells underestimates the true reduction in albumin uptake in
cells overexpressing LIMK-1. This finding compares with the
reduction of TR-albumin uptake to 10.0  2.0% of control
values (n  4; p  0.05) in cells pre-treated with the actin
depolymerizing agent latrunculin A (Fig. 6B). Using the single
cell confocal-based assay, we observed that fluorescein isothio-
cyanate-albumin uptake was effectively abolished in LLC-PK1
cells overexpressing LIMK-1 (n  10, Fig. 6B). A time course
comparing fluorescein isothiocyanate-albumin uptake in cells
with different treatments to inhibit uptake is shown in (Fig.
6B). In addition, in the cells overexpressing LIMK-1, there was
no significant change in the degree of co-localization between
phosphorylated cofilin and ClC-5. The percentage of co-local-
FIG. 1. ClC-5 C terminus binding to cofilin. LLC-PK1 cell lysate
was incubated with either GST or GST-cofilin-agarose beads. A, West-
ern blot showing GST-cofilin binding to ClC-5 in LLC-PK1 lysate. B,
densitometric analysis showing a significant (*, p  0.05; n  3) in-
crease in the amount of ClC-5 binding to GST-cofilin compared with the
GST alone.
FIG. 2. Cofilin distribution in the nuclear, cytoplasmic, and
microsomal fractions. LLC-PK1 cells fractionated and run on a West-
ern blot. Cofilin was found in the nuclear, microsomal (Membrane), and
cytosol fractions.
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ization in LIMK-1-transfected cells was 48  4% (n  8) com-
pared with 63.0  12% (n  8; p  NS) in control cells.
DISCUSSION
There is increasing evidence that the interactions of the
C-terminal tails of ion channels and transporters with other
cellular proteins are critical for many plasma membrane-asso-
ciated functions. These include regulating the trafficking of the
proteins to and from recycling endosomes (10, 13, 32), targeting
the channels for destruction (33), forming macromolecular com-
plexes by means of scaffold proteins that may be anchored to
the cytoskeleton, or conferring spatial specificity on signal
transduction from receptors (34). In this study, we used the C
terminus of ClC-5 in a yeast two-hybrid screen and GST-fusion
protein pulldown assay to demonstrate a physical interaction
between the actin binding protein cofilin and the C-terminal
tail of ClC-5. Furthermore, we showed strong co-localization of
cofilin with ClC-5 in cultured cells of proximal tubule origin,
indicating functional interaction in native cells. Finally, these
data revealed a novel role for cofilin in the regulation of recep-
tor-mediated albumin endocytosis in mammalian proximal tu-
bule cells.
Interactions with the cytoskeleton are essential for the reg-
ulation of ion transport activity and trafficking, control of ves-
icle movement, and endocytosis, as well as assembly of signal-
ing complexes and other macromolecular complexes at the
plasma membrane (10, 13, 34). These interactions involve actin
binding proteins and scaffold proteins as well as other mole-
cules that regulate the dynamics of actin microfilament forma-
tion (for review, see Ref. 35). The apical membranes of polar-
ized epithelial cells have complex structures composed of actin
and actin binding proteins that include the core of the microvil-
lus, the cytoskeletal terminal web underneath the plasma
membrane, and the tight junctional complex that mediates
cell-cell adhesion (22). There are also very high levels of endo-
cytosis associated with the uptake of proteins from the glomer-
ular filtrate and, therefore, in proximal tubule cells, the actin
at the microvillar core and in the terminal actin web must be in
a constant state of remodeling. The importance of an intact
actin cytoskeleton in albumin uptake by proximal tubule cells
has been demonstrated previously (3, 9).
Cofilin is a ubiquitously expressed member of the cofilin/
actin-depolymerizing factor family of actin-associated proteins
(36) that binds to both filamentous (F-actin) and monomeric
(G-actin) actin to stimulate depolymerization of the actin mi-
crofilaments (25). Importantly, cofilin is a terminal effector of
signaling cascades that evoke cytoskeletal rearrangement; co-
filin has been shown to be essential for endocytosis in yeast
(37). One way by which the actin filament-severing activity of
cofilin is terminated is by phosphorylation at Ser3 by LIM
kinase (31, 38).
Cofilin has been reported to interact directly with one other
membrane transport protein. Kim et al. (39) showed that the 
subunit of the Na-K-ATPase binds cofilin by means of inter-
actions with the residues Asp672 and Arg700 of the third cyto-
plasmic domain and, by using confocal immunofluorescence,
that cofilin and Na-K-ATPase co-localized in COS-7 cells
(40). In this study, we divided the C-terminal tail of ClC-5 into
three separate domains of 40–50 residues in length. These
fragments contained a number of charged residues that could
potentially bind cofilin; however, we were unable to detect the
binding of cofilin to these constructs. This suggests that, sim-
ilar to the Na-K-ATPase, the cofilin binding sites in ClC-5
FIG. 3. ClC-5 and cofilin co-localization in LLC-PK1 cells. Confocal microscopy showing endogenous distribution of cofilin and ClC-5 in
LLC-PK1 cells. A, cofilin distribution (green). B, ClC-5 distribution (red). C, merger of images in A and B clearly indicate areas of co-localization
(yellow) between ClC-5 and cofilin. D, AP-2 distribution (blue). E, merger of images in A, B, and C showing areas of co-localization (white) with
ClC-5 and cofilin. F, z axis scan showing the distribution of cofilin (red) in the apical domain. G, z axis scan showing the distribution of ClC-5
concentrated in the apical (AP) region. H, merger of images in F and G showing co-localization of cofilin and ClC-5 (yellow) in the apical region of
the cells. Bar, 10 M.
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may be relatively distant from each other in the protein.
A physiological role for the interaction of cofilin with Na-
K-ATPase was demonstrated by overexpressing cofilin in
COS-7 cells, which resulted in an increase in the activity of
Na-K-ATPase (40). This effect was attributed to the follow-
ing: (i) cofilin providing a necessary interface between the
cytoskeleton and the Na-K-ATPase to allow more pump mol-
ecules to be present in the plasma membrane; or (ii) cofilin
acting to localize Na-K-ATPase molecules to specific mem-
brane regions or to anchor other regulatory proteins to enhance
pump activity (40). Subsequently, Lee and co-workers (41)
found that, in addition to Na-K-ATPase, cofilin also inter-
acted with the glycolytic enzyme triose-phosphate isomerase by
means of a Rho-dependent pathway. This led them to hypoth-
esize that these interactions provided a framework to feed the
Na-K-ATPase with glycolytic ATP that, in turn, enhanced
the pump activity. Importantly, they also showed that cofilin
did not interact with other membrane transporters such as
GLUT1, GLUT4, CFTR, or plasma membrane Ca2-ATPase
(41). Other evidence for the role of cofilin in regulating the
behavior of ion-transporting proteins comes from a study in
guinea pig cardiomyocytes, where cytochalsin D was found to
reduce L-type Ca2 currents (42). The investigators found that
cytochalasin D treatment caused a 50% reduction in the ratio of
phosphorylated to total cofilin content of the heart and con-
cluded that cofilin regulation of F-actin polymerization state
plays an important role in regulating the activity of these Ca2
channels. These studies assign specific roles for cofilin in reg-
ulating ion transport at the plasma membrane. Further sup-
port for a role for actin binding proteins in mediating transport
in epithelial cells comes from studies in intestinal cells, where
stimulation with carbachol results in a redistribution of villin
and F-actin and a reduction in apical NHE3 (43). It is also
known that Rho regulates the activity of NHE3 (11), and it has
been speculated that this may be by means of a cofilin-depend-
ent mechanism (43).
The data from the current study identify a new role for cofilin
in regulating albumin uptake in established cell models of the
proximal tubule. Increasing the levels of phosphorylated cofilin
in cells overexpressing LIM kinase and stabilizing the actin
microfilaments resulted in a significant reduction in albumin
uptake by both OK and LLC-PK1 cells, as measured by two
different assay systems. We also demonstrate that preventing
actin polymerization with latrunculin A or cytochalasin D al-
most totally abolished albumin uptake in these cells. These
FIG. 4. Phosphorylation of cofilin by LIMK-1 in LLC-PK1 cells.
A, Western blot of lysate from cells transfected with c-myc-tagged
LIMK-1. Upper panel, expression of c-myc LIMK-1 in transfected (L)
but not untransfected control cells (U). Lower panel, Western blot for
actin shows equal loading of protein in each lane. B, Western blot of cell
lysate showing an increase in the levels of phosphorylated cofilin (pCo-
filin) in LIMK-1-transfected cells compared with untransfected con-
trols. C, densitometric analysis showing a statistically significant in-
crease (*, p  0.05; n  3) in the levels of phosphorylated cofilin in cells
expressing LIMK-1.
FIG. 5. Actin distribution in OK cells transfected with LIMK-1
or treated with latrunculin A. Actin was visualized in confluent OK
cells with TRITC-phalloidin using confocal microscopy. These images
are representative of three separate experiments. A, untransfected cells
showing actin staining of both the peripheral corona and the filaments
at the base of the microvilli (MV). B, z axis scan showing distribution of
actin at both the apical and basolateral membrane domains. C, disrup-
tion of actin filaments after treatment with latrunculin A (10 M) for
1 h. D, z axis scan showing loss of filamentous actin at the apical and
basolateral membrane domains. E, actin staining in a LIMK-1 trans-
fected cell (*) shows increased staining at the base of the microvilli
(MV), indicating stabilization of the cytoskeleton in this region. Bar, 10
M. F, Cy2 (green) staining of c-myc epitope in cells in E to identify cells
expressing LIMK-1. G, z axis scan showing increased apical actin stain-
ing in a LIMK-1 transfected cell (*) compared with untransfected con-
trol. H, Cy2 (green) staining of c-myc epitope in cells in G to identify
cells expressing LIMK-1. Bar, 10 M.
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data are consistent with the previously observed effects of
cytoskeletal disruption on albumin uptake in OK cells (9).
Importantly, our data demonstrate the crucial role for actin
remodeling within the context of an intact cytoskeleton in
endocytosis in the proximal tubule. Albumin uptake is inhib-
ited by either stabilization of the actin microfilaments (LIMK-1
overexpression) or disruption of the actin cytoskeleton by la-
trunculin A or cytochalasin D.
The data presented here are the first to show that phospho-
rylation of cofilin by LIM kinase in two model proximal tubule
cell lines significantly inhibits the uptake (endocytosis) of al-
bumin. Although LIMK-1 was previously thought to be the
“neuronal” isoform, our demonstration that OK cells express
the mRNA for LIMK-1 is in agreement with a recent study that
revealed the presence of both isoforms of LIM kinase in me-
sangial cells (44). Overexpression of LIM kinase in OK cells
resulted in a stabilization of the actin cytoskeleton, as revealed
by confocal microscopy, and the inhibition of albumin uptake
indicates the need for extensive localized remodeling of actin to
enable endocytosis to occur (22, 24). Furthermore, our data
indicating that phosphorylated cofilin continues to co-localize
with ClC-5 suggest that this association is maintained
throughout the endocytotic cycle.
Our data provide an additional explanation for the pro-
nounced failure of albumin endocytosis mediated by defective
ClC-5 trafficking/channel function in Dent’s disease and high-
light the obligate role of ClC-5 in albumin endocytosis in the
proximal tubule. There is some debate as to whether ClC-5 is
present at the plasma membrane in epithelial cells, as the
electrophysiological evidence is not solid. However, surface bi-
otinylation experiments2 indicate the presence of ClC-5 at the
cell surface. The important point from this study is that, in
terms of our model, because the C-terminal tail of ClC-5 may
act to mediate the assembly and formation of the endocytic
complex (thereby, correctly targeting megalin/cubulin (19) and
H-ATPase (18)), the Cl transporting function of ClC-5 at the
plasma membrane may be redundant. We propose that the
interaction of cofilin with ClC-5 at the plasma membrane plays
a crucial role in mediating actin depolymerization, thus leading
to a highly localized dissolution of the terminal actin web and
facilitating budding of the endosome from the plasma mem-
brane. These findings also highlight the involvement of ClC-5
as a structural component of the endocytotic apparatus rather
than its ion channel activity. Our data are consistent with the
overall concept and models where localized actin depolymeriza-
tion is required for endocytosis and the fact that the area in the
immediate vicinity of clathrin-coated pits are devoid of actin
(24).
Dent’s disease mutations fall broadly into two categories.
They are either non-sense mutations resulting in truncations
or loss of functional protein, or they are mis-sense mutations
that typically reduce the Cl current (e.g. see Ref. 45). Thus,
our findings suggest that, in addition to the defect in acidifica-
tion of the endosomes (as would be expected from mutations
with reduced Cl currents) (6), the endocytotic failure arising
from trafficking mutations of ClC-5 may result from the inabil-
ity of the other proteins involved in albumin uptake to interact
with cofilin and enable efficient movement of the nascent en-
dosome through the cortical actin web. This model explains our
previous data in ClC-5 knockout mice where the endocytosis
appeared to be inhibited at the initial formation of the endo-
some rather than at a downstream early endosomal stage,
where failure of acidification would be expected to be inhibiting
endocytosis (7). It is important to note that H-ATPase is not
required for acidification of the nascent endosome (9, 46, 47),
an observation that supports a role for ClC-5 other than that as
an anion shunt. The novel role we have identified for cofilin will
be important in understanding the complex process of albumin
uptake by the proximal tubule and the mechanisms by which it
is altered in pathophysiological states.
Acknowledgments—We thank Dr. Doug Murphy for his assistance
with the analysis of the endocytosis data. The c-myc-tagged form of
LIMK-1 in pCDNA3 was generously provided by Dr. Pico Caroni
(Friedrich Miescher Institute, Switzerland), and the anti-phosphory-
lated cofilin antibody was provided by Dr. James Bamburg (Colorado
State University, Fort Collins, CO).
REFERENCES
1. Christensen, E., and Birn, H. (2001) Am. J. Physiol. 280, F562–F573
2. Jentsch, T., Friedrich, T., Schriever, A., and Yamada, H. (1999) Pfluegers Arch.
Eur. J. Physiol. 437, 783–795
3. Gekle, M., Serrano, O. K., Drumm, K., Mildenberger, S., Freudinger, R.,
Gassner, B., Jansen, H. W., and Christensen E. I. (2002) Am. J. Physiol.
283, F549–F558
4. Marshansky, V., Ausiello, D. A., and Brown, D. (2002) Curr. Opin. Nephrol.
Hypertens. 11, 527–537
5. Devuyst, O., Christie, P. T., Courtoy, P. J., Beauwens, R., and Thakker, R. V.
(1999) Hum. Mol. Genet. 8, 247–257
2 D. H. Hryciw, Y. Wang, and W. B. Guggino, unpublished data.
FIG. 6. Phosphorylation of cofilin inhibits albumin endocyto-
sis. A, albumin uptake in confluent monolayers of OK cells. OK cells
were transiently transfected with LIMK-1 for 7 days and exposed to
TR-albumin (100 g/ml) for 2 h. TR-albumin uptake was significantly
(*, p  0.05; n  4) inhibited in OK cells treated with latrunculin A (1.5
M for 30 min). B, albumin uptake in single LLC-PK1 cells transfected
with LIMK-1. Cells were exposed to 10 mg/ml of fluorescein isothiocya-
nate-albumin, and uptake was detected in individual cells. Fluorescein
isothiocyanate-albumin rapidly accumulated in control cells (f). Ex-
pression of LIMK-1 (Œ), treatment with cytochalasin D (Œ) (10 M for 40
min), or incubation at 4 °C () resulted in significant decreases in
albumin uptake (*, p  0.05; n  10).
Cofilin Regulation of Albumin Uptake 40175
 at UQ Library on October 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
6. Piwon, N., Gunther, W., Schwake, M., Bosl, M. R., and Jentsch, T. J. (2000)
Nature 408, 369–373
7. Wang, S. S., Devuyst, O., Courtoy, P. J., Wang, X. T., Wang, H., Wang, Y.,
Thakker, R. V., Guggino, S., and Guggino, W. B. (2000) Hum. Mol. Genet. 9,
2937–2945
8. Drumm, K., Gassner, B., Silbernagl, S., and Gekle, M. (2001) Eur. J. Med. Res.
6, 422–432
9. Gekle, M., Mildenberger, S., Freudinger, R., Schwerdt, G., and Silbernagl, S.
(1997) Am. J. Physiol. 272, F668–F677
10. Kim, J., Lee-Kwon, W., Park, J. B., Ryu, S. H., Yun, C. H., and Donowitz, M.
(2002) J. Biol. Chem. 277, 23714–23724
11. Kurashima, K., D’Souza, S., Szaszi, K., Ramjeesingh, R., Orlowski, J., and
Grinstein, S. (1999) J. Biol. Chem. 274, 29843–29849
12. Weinman, E., Steplock, D., and Shenolikar, S. (2001) Kidney Int. 60, 450–454
13. Kurashima, K., Szabo, E. Z., Lukacs, G., Orlowski, J., and Grinstein, S. (1998)
J. Biol. Chem. 273, 20828–20836
14. Biemesderfer, D., Nagy, T., DeGray, B., and Aronson, P. S. (1999) J. Biol.
Chem. 276, 17518–17524
15. Bateman, A. (1997) Trends Biochem. Sci. 22, 12–13
16. Ponting, C. (1997) J. Mol. Med. 75, 160–163
17. Schwake, M., Friedrich, T., and Jentsch, T. J. (2001) J. Biol. Chem. 276,
12049–12054
18. Moulin, P., Igarashi, T., Van Der Smissen, P., Cosyns J.-P., Verroust, P.,
Thakker, R., Scheinman, S. J., Courtoy, P. J., and Devuyst, O. (2003)
Kidney Int. 63, 1285–1295
19. Christensen, E., Devuyst, O., Dom, G., Nielsen, R., Van Der Smissen, P.,
Verroust, P., Leruth, M., Guggino, W. B., and Courtoy, P. J. (2003) Proc.
Natl. Acad. Sci. U. S. A. 100, 8472–8477
20. Zhai, X. Y., Nielsen, R., Birn, H., Drumm, K., Mildenberger, S., Freudinger, R.,
Moestrup, S. K., Verroust, P. J., Christensen, E. I., and Gekle, M. (2000)
Kidney Int. 58, 1523–1533
21. Schwegler, J., Heppelmann, B., Mildenberger, S., and Silbernagl, S. (1991)
Pfluegers Arch. Eur. J. Physiol. 418, 383–392
22. Apodaca, G. (2001) Traffic 2, 149–159
23. Qualmann, B., Kessels, M. M., and Kelly, R. B. (2000) J. Cell Biol. 150,
F111–F116
24. Fujimoto, L., Roth, R., Heuser, J. E., and Schmid, S. L. (2000) Traffic 1,
161–171
25. Bamburg, J. (1999) Annu. Rev. Cell Dev. Biol. 15, 185–230
26. Ashworth, S. L., Southgate, E. L., Sandoval, R. M., Meberg, P. J., Bamburg,
J. R., and Molitoris B. A. (2003) Am. J. Physiol. 284, F852–F862
27. Wylie, F., Heimann, K., Luam Le, T., Brown, D., Rabnott, G., and Stow, J. L.
(1999) Am. J. Physiol. 276, C497–C506
28. Negoescu, A., Labat-Moleur, F., Lorimier, P., Lamarcq, L., Guillermet, C.,
Chambaz, E., and Brambilla, E. (1994) J. Histochem. Cytochem. 42,
433–437
29. Meberg, P., Ono, S., Minamide, L. S., Takahashi, M., and Bamburg, J. R.
(1998) Cell Motil. Cytoskeleton 39, 172–190
30. Wohlfarth, V., Drumm, K., Mildenberger, S., Freudinger, R., and Gekle, M.
(2003) Kidney Int. 84, 103–109
31. Arber, S., Barbayannis, F. A., Hanser, H., Schneider, C., Stanyon, C. A.,
Bernard, O., and Caroni, P. (1998) Nature 393, 805–809
32. Weinman, E. J., Minkoff, C., and Shenolikar, S. (2000) Am. J. Physiol. Renal
Physiol. 279, F393–F399
33. Staub, O., Gautschi, I., Ishikawa, T., Breitschopf, K., Ciechanover, A., Schild,
L., and Rotin, D. (1997) EMBO J. 16, 6325–6336
34. Naren, A., Cobb, B., Li, C., Roy, K., Nelson, D., Heda, G. D., Liao, J., Kirk,
K. L., Sorscher, E. J., Hanrahan, J., and Clancy, J. P. (2003) Proc. Natl.
Acad. Sci. U. S. A. 100, 342–346
35. Brown, D., and Breton, S. (2000) Kidney Int. 57, 816–824
36. Moon, A., and Drubin, D. G. (1995) Mol. Biol. Cell 6, 1423–1431
37. Lappalainen, P., and Drubin, D. G. (1997) Nature 388, 78–82
38. Lawler, S. (1999) Curr. Biol. 9, R800–R802
39. Kim, M., Jung, J., Park, C. S., and Lee, K. (2002) Biochimie (Paris) 84,
1021–1029
40. Lee, K., Jung, J., Kim, M., and Guidotti, G. (2001) Biochem. J. 353, 377–385
41. Jung, J., Yoon, T., Choi, E. C., and Lee, K. (2002) J. Biol. Chem. 277,
48931–48937
42. Rueckschloss, U., and Isenberg, G. (2001) J. Physiol. (Lond.) 537, 363–370
43. Khurana, S. (2000) J. Membr. Biol. 178, 73–87
44. Shabahang, S., Huwiler, A., and Pfeilschifter, J. (2002) Biochem. Biophys. Res.
Commun. 298, 408–413
45. Lloyd, S., Pearce, S. H., Fisher, S. E., Steinmeyer, K., Schwappach, B., Scheinman,
S. J., Harding, B., Bolino, A., Devoto, M., Goodyer, P., Rigden, S. P., Wrong, O.,
Jentsch, T. J., Craig, I. W., and Thakker, R. V. (1996) Nature 379, 445–449
46. Aniento, F., Gu, F., Parton, R. G., and Gruenberg, J. (1996) J. Cell Biol. 133,
29–41
47. Van Deurs, B., Holm, P. K., and Sandvig, K. (1996) Eur. J. Cell Biol. 69,
343–350
Cofilin Regulation of Albumin Uptake40176
 at UQ Library on October 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
and William B. Guggino
Deanne H. Hryciw, Yinghong Wang, Olivier Devuyst, Carol A. Pollock, Philip Poronnik
Lines
Cofilin Interacts with ClC-5 and Regulates Albumin Uptake in Proximal Tubule Cell
doi: 10.1074/jbc.M307890200 originally published online August 6, 2003
2003, 278:40169-40176.J. Biol. Chem. 
  
 10.1074/jbc.M307890200Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/278/41/40169.full.html#ref-list-1
This article cites 47 references, 14 of which can be accessed free at
 at UQ Library on October 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
